opening song

“Saw Palmetto Extract and Benign Prostatic Hyperplasia Treatment: Exploring Over-The-Counter Medicines, Health Functional Foods, and Clinical Options”

2023-05-01 20:30:00 Amid the recent trend of increasing patients with benign prostatic hyperplasia due to the aging population, the related treatment market is also excited. Among them, ‘Saw Palmetto Extract (Serenoa repens)’ is attracting attention again. In the clinical field, it has already been recognized for its therapeutic effect in Europe, etc. According to the … Read more

Samjin Pharm acquires right to sell Masiten Tablets, a treatment for pulmonary arterial hypertension

2023-04-27 03:09:12 Samjin Pharmaceutical announced on the 27th that it obtained priority sale permission from the Ministry of Food and Drug Safety on the 21st following patent avoidance following a trial decision cited by the Intellectual Property Tribunal for a passive right scope confirmation trial on the 19th for the pulmonary arterial hypertension treatment ‘Maciten … Read more

Ministry of Food and Drug Safety temporarily suspends the manufacture, sale, and use of Dong-A Pharmaceutical Champ Syrup

2023-04-25 13:04:31 As a result of collecting and inspecting Dong-A Pharmaceutical’s ‘Champ Syrup (acetaminophen)’, which had a browning phenomenon, two batch numbers were judged unsuitable. The Ministry of Food and Drug Safety converted the item to ‘forced recall’ and took measures to ‘voluntarily recall’ the rest of the manufacturing numbers. On the 25th, the Ministry … Read more

Domestic companies who threw their votes for AACR… Next-generation anticancer drug challenge

A domestic biopharmaceutical company is going to the American Association for Cancer Research annual conference (AACR 2023) to publicize the clinical data of new anti-cancer drugs being developed on the international stage. As AACR is considered the world’s largest international academic event in the field of oncology, we are looking at plans for technology export … Read more

Diabetes drug market change… Accelerating pharmaceutical companies bleeding competition

“I don’t think there have been as many salespeople from pharmaceutical companies as there are these days.” The diabetes treatment market, which has grown close to the total market of 1.3 trillion won, has faced a major change since April. As the ‘expanding of concomitant benefits by diabetes treatment class’, which had been on hold … Read more

Updating the standard childhood immunization strategy… HPV from age 11

In 2023, the standard vaccination strategy for children and adolescents was updated. The human papillomavirus vaccine (HPV) was changed from the age of 12 to 11, and the interval between vaccinations for the Japanese encephalitis vaccine also changed. On the 24th, the Korean Vaccine Society held the 21st Spring Conference at L Convention and shared … Read more

Benefits of age before liver cancer treatment… Older people also have a higher prognosis

Hanah Lee, planning committee member of the Liver Cancer Association (Division of Gastroenterology, Ewha Womans University Mokdong Hospital) While the number of elderly patients with liver cancer is increasing, a study has found that the prognosis during treatment intervention is similar to that of non-elderly patients. In particular, in the case of advanced liver cancer … Read more

Cardiovascular disease is the leading cause of death in diabetes? In fact, more cancers

Cancer, not cardiovascular disease, is the leading cause of death in type 2 diabetes, a new study has found. This breaks the conventional wisdom that the cause of death in diabetes is a cardiovascular disease complication, suggesting the need for a multidisciplinary approach. The results of a study on the mortality rate of patients with … Read more